BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18426897)

  • 1. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
    Durand-Gasselin L; Pruvost A; Dehée A; Vaudre G; Tabone MD; Grassi J; Leverger G; Garbarg-Chenon A; Bénech H; Dollfus C
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2555-63. PubMed ID: 18426897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
    Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
    Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Plasma Concentrations of Zidovudine (AZT) Do Not Parallel Intracellular Concentrations of AZT-Triphosphates in Infants During Prevention of Mother-to-Child HIV-1 Transmission.
    Kinai E; Kato S; Hosokawa S; Sadatsuki M; Gatanaga H; Kikuchi Y; Lam NV; Ha do Q; Kinh NV; Liem NT; Oka S
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):246-53. PubMed ID: 26859826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
    Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
    Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals.
    Rodriguez JF; Rodriguez JL; Santana J; García H; Rosario O
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3097-100. PubMed ID: 11036029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
    Haaland RE; Otieno K; Martin A; Katana A; Dinh C; Slutsker L; Menendez C; Gonzalez R; Williamson J; Heneine W; Desai M
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):912-915. PubMed ID: 30173559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
    Kinai E; Gatanaga H; Kikuchi Y; Oka S; Kato S
    J Mass Spectrom; 2015 Jun; 50(6):783-91. PubMed ID: 26169132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitation of the 5'-triphosphate metabolites of zidovudine, lamivudine, and stavudine in peripheral mononuclear blood cells of HIV infected patients by high-performance liquid chromatography tandem mass spectrometry.
    Moore JD; Valette G; Darque A; Zhou XJ; Sommadossi JP
    J Am Soc Mass Spectrom; 2000 Dec; 11(12):1134-43. PubMed ID: 11118121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
    Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
    J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
    Bazzoli C; Bénech H; Rey E; Retout S; Salmon D; Duval X; Tréluyer JM; Mentré F;
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3423-31. PubMed ID: 21576446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
    McIntyre JA; Hopley M; Moodley D; Eklund M; Gray GE; Hall DB; Robinson P; Mayers D; Martinson NA
    PLoS Med; 2009 Oct; 6(10):e1000172. PubMed ID: 19859531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.
    Lambert JS; Nogueira SA; Abreu T; Machado ES; Costa TP; Bondarovsky M; Andrade M; Halpern M; Barbosa R; Perez M
    Sex Transm Infect; 2003 Dec; 79(6):448-52. PubMed ID: 14663118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients.
    Robbins BL; Tran TT; Pinkerton FH; Akeb F; Guedj R; Grassi J; Lancaster D; Fridland A
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2656-60. PubMed ID: 9756772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.
    Vrouenraets SM; Wit FW; Garcia EF; Huber M; Brinkman K; Moyle G; Domingo P; Tarr PE; Podzamczer D; Ristola M; Gatell JM; Livrozet JM; Furrer H; Reiss P;
    HIV Clin Trials; 2012; 13(2):103-10. PubMed ID: 22510357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania.
    Ziske J; Kunz A; Sewangi J; Lau I; Dugange F; Hauser A; Kirschner W; Harms G; Theuring S
    PLoS One; 2013; 8(2):e55633. PubMed ID: 23405185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.